Nordic Capital- and Avista Capital Partners-backed ConvaTec, a UK-based distributor of medical products, has priced its IPO on the London stock exchange, giving it a market cap of £4.39bn.
Shares are sold by shares were held by CapMan Buyout X Fund A and CapMan Buyout X Fund B
Advent made a takeover offer of 165 pence per share in cash, which represents a 34% premium in July
Business strategy platform will expand its product and triple its team size
Fund targets companies operating in the healthcare industry, primarily pharma, medtech and outsourced services